CRP and colorectal carcinoma: CRP is a well-recognized hallmark of inflammation and has been shown to be an adequate inflammation-based and feasible prognostic marker for CRC, whereby increased plasma levels are associated with a worse prognosis for CRC [71,72], larger tumor size [63], higher recurrence rates [73], and decreased overall survival [63].